International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.09 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 202 shares trading hands.
International Stem Cell Trading Up 117.7 %
The company has a market capitalization of $907,200.00, a PE ratio of -1.89 and a beta of 0.25. The stock has a fifty day simple moving average of $0.09 and a 200-day simple moving average of $0.09.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last announced its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($0.03) EPS for the quarter. The business had revenue of $2.13 million for the quarter.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- How to Use High Beta Stocks to Maximize Your Investing Profits
- RXO Shares Surge Following New Acquisition Deal
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Golden Cross Stocks: Pattern, Examples and Charts
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
